https://www.aigom.it/wp-content/uploads/2026/11/Screenshot-2026-11-10-105335.png862931Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-11-10 09:55:492026-11-10 09:55:49TOPICAL DICLOFENAC FOR PREVENTION OF CAPECITABINE-INDUCED HAND-FOOT SYNDROME: A PROSPECTIVE REAL-WORLD STUDY.
https://www.aigom.it/wp-content/uploads/2026/11/art-3.11.png842595Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-11-03 07:42:052026-11-03 07:42:05MULTICENTER COHORT STUDY OF ORIGINAL OR SUBSTITUTE SYSTEMIC THERAPY WITH OR WITHOUT BRAIN RADIOTHERAPY FOR EXTENSIVE-STAGE SMALL CELL LUNG CANCER WITH BRAIN-ONLY PROGRESSION AFTER FIRST-LINE TREATMENT.
https://www.aigom.it/wp-content/uploads/2026/10/ART20.10.png856500Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-10-20 09:56:172026-10-20 09:56:17TIME-VARYING HAZARD RATES REVEAL PATTERNS OF PROGRESSION IN HR+/HER2-METASTATIC BREAST CANCER: TOWARDS RISK-ADAPTED MONITORING.
https://www.aigom.it/wp-content/uploads/2026/10/ART6.10.png778500Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-10-06 10:10:042026-10-06 10:10:04WATCH AND WAIT FOR RECTAL CANCER: A RISKY GAMBLE OR A SAFE STRATEGY FOR PATIENTS WITH A NEAR-COMPLETE RESPONSE?
https://www.aigom.it/wp-content/uploads/2026/09/ART29.9.png737500Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-09-29 13:40:242026-09-29 13:57:24CLINICAL VALIDATION OF A CIRCULATING TUMOR DNA-BASED BLOOD TEST TO SCREEN FOR COLORECTAL CANCER.
https://www.aigom.it/wp-content/uploads/2026/09/ART.22.9.png672450Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-09-22 08:39:242026-09-22 08:39:24A META-ANALYSIS IDENTIFIES DRIVER GENES AND CHARACTERIZES THE MOLECULAR EPIDEMIOLOGY OF COLORECTAL CANCER.
https://www.aigom.it/wp-content/uploads/2026/09/COP.15.9-1.png609500Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-09-15 08:44:562026-09-15 08:47:19EXPLORING ALTERNATIVES TO TUMOR TISSUE FOR BRCA1/2 NEXT-GENERATION SEQUENCING TESTING IN HIGH-GRADE SEROUS OVARIAN CANCER: A 34-CASE OF MALIGNANT ASCITES.
https://www.aigom.it/wp-content/uploads/2026/07/ART217A-1.png606400Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2026-07-21 15:42:512026-07-21 16:16:48THERAPY FOR STAGE IV NON-SMALL CELL LUNG CANCER WITH DRIVER ALTERATIONS: ASCO LIVING GUIDELINE, 2026.3.1.
